Even if only US shifts 20-30%, Indian API revenues could triple or quadruple in 10 years

Discussion in 'Latest Brokerage Stock Buy-Sell Reports' started by Vidhi Khanna, Sep 8, 2024 at 12:00 PM.

Tags:
Previous Thread Next Thread
Loading...
  1. Vidhi Khanna

    Vidhi Khanna Active Member Staff Member

    Joined:
    Mar 19, 2015
    Messages:
    641
    Likes Received:
    55
    Aditya Khemka says the US' Biosecure Act will benefit Pharma Cos like Piramal Pharma & Jubilant Pharmova which have mfg facilities in the US as they will be the first order beneficiary. Indian API exports are $4B while China's API exports are $40B. Even if only US shifts 20-30%, Indian API revenues could triple or quadruple in 10 years

     
    Vidhi Khanna, Sep 8, 2024 at 12:00 PM
    #1
Previous Thread Next Thread
Loading...